Venous thromboembolism
Therapeutic area
Vascular Medicine
Rare disease
No
- Definition
- Occlusion of the lumen of a vein by a thrombus that has migrated from a distal site via the blood stream.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Venous thromboembolism
- Therapeutic area
- Vascular Medicine
- venous thromboembolism
- venous thromboembolism
- Severity
- Severe
- Cardiology
- Vascular Medicine
- MONDO ID
- MONDO:0005399
- Parent condition
- MONDO:0005385
Related records
Broader conditions (5)
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Human disease
- Vascular disorder
Trials (684)
- : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery
- 3D-EIT for Diagnosis and Monitoring of Pulmonary Embolism
- 5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders
- A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
- A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens
- A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery
- A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
- A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness
- A Different Approach to Preventing Thrombosis
- A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
- A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
- A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
- A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection
- A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
- A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic
- A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)
- A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
- A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Approved drugs (7)
- Apixaban
- Betrixaban
- Dabigatran etexilate mesylate
- Dalteparin sodium
- Edoxaban tosylate
- Enoxaparin sodium
- Rivaroxaban
Drugs in development (29)
- Abelacimab Phase 3
- Anti-psgl-1 antibody SELK2 Phase 2
- Aspirin Phase 3
- Atorvastatin Early phase 1
- Ciraparantag Phase 2
- Clarithromycin Phase 1
- Clopidogrel Phase 2
- Colchicine Phase 3
- Cyclosporine Phase 1
- Dabigatran Phase 3
- Dabigatran etexilate Phase 3
- Darexaban Phase 3
- Edoxaban Phase 3
- Fondaparinux Phase 3
- Fondaparinux sodium Phase 3
- GW813893 Phase 2
- Heparin Phase 3
- Heparin sodium Phase 3
- Letaxaban Phase 2
- Nadroparin calcium Phase 3
Other linked drugs (2)
- Protein C concentrate (human)
- Tinzaparin